Somatostatin or octreotide as treatment options for chylothorax in young children: A systematic review

Intensive Care Medicine

Volumn 32, Issue 5, 2006, Pages 650-657

  Roehr, Charles C ^a   Jung, Andreas ^a   Proquitté, Hans ^a   Blankenstein, Oliver ^a   Hammer, Hannes ^a   Lakhoo, Kokila ^b   Wauer, Roland R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Chylothorax; Infant; Octreotide; Pleural effusion; Somatostatin

Indexed keywords

OCTREOTIDE; SOMATOSTATIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ANOREXIA; AORTA COARCTATION; ASPLENIA; BRADYCARDIA; CAVERNOUS SINUS THROMBOSIS; CHOLELITHIASIS; CHYLOTHORAX; CLINICAL TRIAL; COCHRANE LIBRARY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; EMBASE; FLU LIKE SYNDROME; FLUSHING; GLUCOSE INTOLERANCE; GROWTH RETARDATION; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTHYROIDISM; HYPOXEMIA; ILEUS; INFARCTION; INJECTION SITE PAIN; INTESTINE PERFORATION; LIVER DYSFUNCTION; LOOSE FECES; MEDLINE; META ANALYSIS; NAUSEA; NECROTIZING ENTEROCOLITIS; PULMONARY HYPERTENSION; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; WEIGHT REDUCTION;

CHILD, PRESCHOOL; CHYLOTHORAX; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; OCTREOTIDE; SOMATOSTATIN; TREATMENT OUTCOME;

EID: 33646389281     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0114-9     Document Type: Review

References (56)

1. Buttiker V, Fanconi S, Burger R (1999) Chylothorax in children: guidelines for diagnosis and management. Chest 116:682-687
2. van Straaten HL, Gerards LJ, Krediet TG (1993) Chylothorax in the neonatal period. Eur J Pediatr 152:2-5
3. Efrati O, Barak A (2002) Pleural effusions in the pediatric population. Pediatr Rev 12:417-426
4. Dubin PJ, King IN, Gallagher PG (2000) Congenital chylothorax. Curr Opin Pediatr 12:505-509
5. Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le Coultre C (2000) Etiology and management of pediatric chylothorax. J Pediatr 136:653-658
6. Hagay Z, Reece A, Roberts A, Hobbins JC (1993) Isolated fetal pleural effusion: a prenatal management dilemma. Obstet Gynecol 81:147-152
7. Bessone LN, Ferguson TB, Burford TH (1971) Chylothorax. Ann Thorac Surg 12: 527-550
8. Chernick V, Reed MH (1970) Pneumothorax and chylothorax in the neonatal period. J Pediatr 76:624-632
9. van Aerde J, Campbell AN, Smyth JA, Lloyd D, Bryan MH (1984) Spontaneous chylothorax in newborns. AJDC 138:961-964
10. Cormack BE, Wilson NJ, Finucane K, West TM (2004) Use of Monogen for pediatric postoperative chylothorax. Ann Thorac Surg 77:301-305
11. Romero S (2000) Nontraumatic chylothorax. Curr Opin Pulm Med 6:287-291
12. Puntis JW, Roberts KD, Handy D (1987) How should chylothorax be managed? Arch Dis Child 62:593-596
13. Wasmuth-Pietzuch A, Hansmann M, Bartmann P, Heep A (2004) Congenital chylothorax: lymphopenia and high risk of neonatal infections. Acta Paediatr 93:220-224
14. Seneff MG, Corwin RW, Gold LH, Irwin RS (1986) Complications associated with thoracocentesis. Chest 90:97-100
15. Fernandez Alvarez JR, Kalache KD, Grauel EL (1999) Management of spontaneous congenital chylothorax: oral medium-chain triglycerides versus total parenteral nutrition. Am J Perinatol 16:415-420
16. Mussat P, Dommergues M, Parat S, Mandelbrot L, de Gamarra E, Dumez Y, Moriette G (1995) Congenital chylothorax with hydrops: postnatal care and outcome following antenatal diagnosis. Acta Paediatr 84:749-755
17. Mohan H, Paes ML, Haynes S (1999) Use of intravenous immunoglobulins as an adjunct in the conservative management of chylothorax. Paediatr Anaesth 9: 89-92
18. Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez JL (2003) Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed 88:F531-533
19. Al-Tawil K, Ahmed G, Al-Hathal M, Al-Jarallah Y, Campbell N (2000) Congenital chylothorax. Am J Perinatol 17:121-126
20. Rimensberger PC, Muller-Schenker B, Kalangos A, Beghetti M (1998) Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 66:253-254
21. Cheung Y, Leung MP, Yip M (2001) Octreotide for treatment of postoperative chylothorax. J Pediatr 139:157-159
22. Cochrane Library: http://www.update-software.com/clibng/cliblogon.htm. Accessed 25.05.2005
23. EMBASE: http://web5.silverplatter.com/webspirs.ws. Accessed 25.05.2005
24. Pubmed: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=idecuhmlib. Accessed 25.05.2005
25. Philips B, Ball C, Sackett D, Badenough D, Straus S, Dawes M. http://www.cebm.net/levels_of_evidence.asp . Accesed 25.05.2005
26. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012
27. Clarke SA, Lakhoo K, Sherwood W (2005) Somatostatin for intractable postoperative chylothorax in a premature infant. Pediatr Surg Int 21:390-391
28. Matsuo T, Matsumoto M, Sugita T (2003) Treatment of persistent chylothorax with somatostatin. Ann Thorac Surg 76:340-341
29. Pettitt TW, Caspi J, Borne A (2002) Treatment of persistent chylothorax after Norwood procedure with somatostatin. Ann Thorac Surg 73:977-979
30. Buettiker V, Hug MI, Burger R, Baenziger O (2001) Somatostatin: a new therapeutic option for the treatment of chylothorax. Intensive Care Med 27:1083-1086
31. Markham KM, Glover JL, Welsh RJ, Lucas RJ, Bendick PJ (2000) Octreotide in the treatment of thoracic duct injuries. Am Surg 66:1165-1167
32. Roehr CC, Jung A, Curcin OA, Proquitte H, Hammer H, Wauer R (2005) Loculated neonatal chylothorax treated with Octreotide: complete recovery whilst on unrestricted full fat breast milk. Ann Thorac Surg 80:1981-1982
33. Mohseni-Bod H, Macrae D, Slavik Z (2004) Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: Is it safe? Pediatr Crit Care Med 5:356-357
34. Hamdan MA, Gaeta ML (2004) Octreotide and low-fat breast milk in postoperative chylothorax. Ann Thorac Surg 77:2215-2217
35. Tibballs J, Soto R, Bharucha T (2004) Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion. Ann Thorac Surg 77:2213-2215
36. Lam JC, Aters S, Tobias JD (2001) Initial experience with octreotide in the pediatric population. Am J Ther 8:409-415
37. Al-Zubairy SA (2003) Octreotide as a therapeutic option for management of chylothorax. Ann Pharm 37:679-682
38. Pratap U, Slavik Z, Ofoe VD, Onuzo O, Franklin RC (2001) Octreotide to treat postoperative chylothorax after cardiac operations in children. Ann Thorac Surg 72:1740-1742
39. Rosti L, Bini RM, Chessa M, Somato G, Drago M, Carminati M (2002) The effectiveness of octreotide in the treatment of post-operative chylothorax. Eur J Pediatr 161:149-150
40. Goyal A, Smith NP, Jesudason EC, Kerr S, Losty P (2003) Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia. J Pediatr Surg 38:E32
41. Aleo Lujan E, Uran Moreno MM, Brandstrup Azuero KB, Lopez-Herce Cid J, Zunzunegui Martinez JL (2003) Octreotide treatment of post surgical chylothorax. An Pediatr (Barc) 58:390-392
42. Au M, Weber TR, Fleming RE (2003) Successful use of Somatostatin in a case of neonatal chylothorax. J Pediatr Surg 38:1106-1107
43. Goto M, Kawamata K, Kitano M (2003)Treatment of chylothorax in a premature infant using Somatostatin. J Perinatol 23:563-564
44. Coulter DM (2004) Successful treatment with octreotide of spontaneous chylothorax in a premature infant. J Perinatol 24:194-195
45. Sivasli E, Dogru D, Tana Aslan A, Yurdakok M, Tekinalp G (2004) Spontaneous neonatal chylothorax treated with octreotide in Turkey: a case report. J Perinatol 24:261-262
46. Young S, Dalgleish S, Eccleston A, Akierman A, McMillan D (2004) Severe congenital chylothorax treated with octreotide. J Perinatol 24:200-202
47. Rasiah SV, Oei J, Lui K (2004) Octreotide in the treatment of congenital chylothorax. J Paediatr Child Health 40:585-588
48. Lauterbach R, Sczaniecka B, Koziol J, Knapczyk M (2005) Somatostatin treatment of spontaneous chylothorax in an extremely low birth weight infant. Eur J Pediatr 164:195-196
49. Ottinger J (2002)Octreotide for persistent chylothorax in a paediatric patient. Ann Pharmacother 36:1106-1107
50. Maayan-Metzger A, Sack J, Mazkereth R, Kuint J (2005) Somatostatin treatment of congenital chylotothrax may induce transient hypothyroidism newborns. Acta Paediatr 94:785-789
51. Leelahanon S, Petlek W, Sontimuang W, Pochanart P, Tepakorn V, Ruangpeg S (2003) Can octreotide be the first line treatment for chylothorax? J Med Assoc Thai 86 Suppl 3:S741-745
52. Ziedalski TM, Raffin TA, Sze DY, Mitchell JD, Robbins RC, Theodore J, Faul JL (2004) Chylothorax after heart/lung transplantation. J Heart Lung Transplant 23:627-631
53. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ (1996) Octreotide. N Engl J Med 334:246-254
54. Tauber MT, Harris AG, Rochiccioli P (1994) Clinical use of the long acting somatostatin analogue octreotide in pediatrics. Eur J Pediatr 153:304-310
55. Glaser B, Hirsch HJ, Landau H (1993) Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr 123:644-650
56. Ditchfield MR, Hutson JM (1998) Intestinal rotational abnormalities in polysplenia and asplenia syndromes. Pediatr Radiol 28:303-306